Gonca Bektaş, Melike Ersoy Olbak, Bülent Uyanık, Gül Demet Kaya Ozcora

Inherited metabolic disorders among Turkish children withintellectual disability: A single-center experience

Aim: We aimed to determine the frequency of inherited metabolic disorders (IMD) among Turkish children with intellectual disabilityusing laboratory tests for IMD. Materials and Methods: Children older than 5 years of age with intellectual disability admitted to the Pediatric Neurology OutpatientClinic for any neurological symptom between July 1, 2018, and December 31, 2018 were analyzed. Children with intellectual disabilityof unknown etiology at admission were included in the study. Complete blood count, serum biochemical analysis, thyroid functiontests, serum ammonia, lactate, homocysteine, biotinidase activity, serum amino acids, acylcarnitine profile, and urine organic acidanalysis results were evaluated. Results: A total of 163 patients (108 boys) were included in the study. The female to male ratio was 1: 2. The ages of the patientswere between 5 and 17 years and the mean age was 9.4 ± 3.6 years. Four patients were diagnosed with IMD. Two of them hadmitochondrial disease, 1 of them had isovaleric acidemia, and 1 of them had 3-Methylcrotonyl-CoA carboxylase deficiency. Theaccompanying symptoms of intellectual disability were psychiatric symptoms, dysarthria, ataxia, tremor and seizure in childrendiagnosed with IMD. We found that the percentage of IMD was 2.5% among Turkish children with intellectual disability. Conclusion: In our study, all IMDs identified in children with intellectual disability were treatable. That result emphasizes thesignificance of evaluating children for inherited metabolic disorders among children with intellectual disability.

PDF

___

1. García-Cazorla A, Wolf NI, Serrano M, et al. Mental retardation and inborn errors of metabolism. J Inherit Metab Dis 2009;32:597-608.
2. Salvador-Carulla L, Reed GM, Vaez-Azizi LM, Cooper SA, Martinez-Leal R, Bertelli M, et al. Intellectual developmental disorders: towards a new name, definition and framework for “mental retardation/ intellectual disability” in ICD-11. World Psychiatry 2011;10:175-80.
3. Shevell M, Ashwal S, Donley D, et al. Practice parameter: evaluation of the child with global developmental delay— report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 2003;60:367-80.
4. Curry CJ, Stevenson RE, Aughton D, et al. Evaluation of mental retardation: recommendations of a Consensus Conference: American College of Medical Genetics. Am J Med Genet 1997;72:468-77.
5. van Karnebeek CD, Jansweijer MC, Leenders AG, et al. Diagnostic investigations in individuals with mental retardation: a systematic literature review of their usefulness. Eur J Hum Genet 2005;13:6-25.
6. van Karnebeek CD, Scheper FY, Abeling NG, et al. Etiology of mental retardation in children referred to a tertiary care center: a prospective study. Am J Ment Retard 2005;110:253-67.
7. Moeschler JB, Shevell M; American Academy of Pediatrics Committee on Genetics. Clinical genetic evaluation of the child with mental retardation or developmental delays. Pediatrics 2006;117:2304-16.
8. Sayson B, Popurs MA, Lafek M, et al. Retrospective analysis supports algorithm as efficient diagnostic approach to treatable intellectual developmental disabilities. Mol Genet Metab 2015;115:1-9.
9. Arlington. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. 5th ed. American Psychiatric Association; 2013.
10. Farag TI, al Awadi SA, el Badramary MH, et al. Disease profile of 400 institutionalized mentally retarded patients in Kuwait. Clin Genet 1993;44:329-34.
11. Matilainen R, Airaksinen E, Mononen T, et al. A population-based study on the causes of mild and severe mental retardation. Acta Paediatr 1995;84:261- 6.
12. Kazanasmaz H, Karaca M. Comparison of Fluorometric İmmunoassay and Tandem Mass Spectrometry Methods Used in the Diagnosis of Phenylalanine Metabolism Disorders in Turkish Children. İstanbul Med J 2019;20:279-84.
13. Kazanasmaz H, Atas N, Karaca M. Specificity and sensitivity of biotinidase activity measured from dried blood spot by colorimetric method. Ann Med Res 2019;26:2306-11.
14. van Karnebeek CD, Stockler S. Treatable inborn errors of metabolism causing intellectual disability: a systematic literature review. Mol Genet Metab 2012;105:368-81.
15. van Karnebeek CD, Stockler-Ipsiroglu S. Early identification of treatable inborn errors of metabolism in children with intellectual disability: the treatable intellectual disability endeavor protocol in British Columbia. Paediatr Child Health 2014;19:469-71